ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $585,367 | +102596.0% | 66,293 | -11.2% | 0.02% | 0.0% |
| Q4 2022 | $570 | -99.9% | 74,655 | +19.1% | 0.02% | +14.3% |
| Q3 2022 | $446,000 | +26.3% | 62,701 | +43.6% | 0.01% | +40.0% |
| Q2 2022 | $353,000 | +8.6% | 43,669 | +86.5% | 0.01% | +25.0% |
| Q1 2022 | $325,000 | -27.8% | 23,412 | +45.9% | 0.01% | -27.3% |
| Q4 2021 | $450,000 | -50.8% | 16,042 | -40.4% | 0.01% | -47.6% |
| Q3 2021 | $915,000 | -15.5% | 26,921 | +1.5% | 0.02% | -12.5% |
| Q2 2021 | $1,083,000 | +30.6% | 26,514 | +28.8% | 0.02% | +26.3% |
| Q1 2021 | $829,000 | -15.1% | 20,583 | +24.6% | 0.02% | -5.0% |
| Q4 2020 | $977,000 | +71.1% | 16,524 | +40.8% | 0.02% | +53.8% |
| Q3 2020 | $571,000 | – | 11,737 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |